Description
Clinical Trials and Efficacy
A clinical trial sponsored by Neutec Ar-Ge San ve Tic A.Ş was conducted to evaluate the bronchodilator efficacy of Formoterol/Budesonide 12/400 mcg via Discair® in patients with COPD. The trial assigned patients to receive a single dose of the fixed combination medication and spirometric measurements were taken at various intervals for 12 hours.
Results showed that the medication was effective in improving lung function as indicated by spirometric measurements. The combination of Formoterol/Budesonide showed bronchodilator efficacy and improved the symptoms of COPD patients for 12 hours post-treatment.
Common Side Effects
Like any medication, Forpack Discair Inhalation Icin Powder 400 Mcg has potential side effects. Some of the commonly reported side effects include headache, nausea, vomiting, stomach discomfort, dizziness, and respiratory tract infection 34. However, these symptoms are usually mild and resolve on their own.
It’s important to note that not everyone experiences side effects, and that everyone reacts differently to medications. If you experience any side effects, it is important to talk to your doctor.
Conclusion
Forpack Discair Inhalation Icin Powder 400 Mcg is a highly effective bronchodilator medication that combines Formoterol/Budesonide to improve lung function in COPD patients. Clinical trials have shown the medication to be effective for 12 hours post-treatment. Although some side effects have been reported, they are generally mild and resolve on their own. If you have any concerns about the medication or experience any side effects, please consult with your doctor.
Reviews
There are no reviews yet.